Amar Kishan, MD, on Optimal Sequencin... - Prostate Cancer N...

Prostate Cancer Network

5,386 members3,426 posts

Amar Kishan, MD, on Optimal Sequencing of ADT With RT in Nonmetastatic Prostate Cancer

Yearofthecow profile image
7 Replies

"For patients with nonmetastatic prostate cancer, the optimal sequencing of short-term androgen-deprivation therapy (ADT) when delivered with radiotherapy (RT) has been uncertain. Only two randomized trials have investigated this question. Now, however, a study in the Journal of Clinical Oncology, has provided more definitive evidence.

Amar Kishan, MD, of the University of California Los Angeles, and colleagues pooled individual data from 7,409 patients in 12 randomized trials. The patients were treated with RT and short-term neoadjuvant/concurrent ADT (n=6,325) or concurrent/adjuvant ADT (n=1,084), and outcomes were examined by RT field size.

In men who received prostate-only radiotherapy (PORT), concurrent/adjuvant ADT was associated with improved metastasis-free survival (10-year benefit 8.0%, HR 0.65, P<0.0001) and overall survival (HR 0.69, P<0.0001).

"These data strongly suggest that when PORT is being delivered with short-term ADT -- as is recommended for men with intermediate-risk disease -- concurrent/adjuvant ADT sequencing should be the standard of care," the researchers concluded."

medpagetoday.com/reading-ro...

Written by
Yearofthecow profile image
Yearofthecow
To view profiles and participate in discussions please or .
Read more about...
7 Replies
Darryl profile image
DarrylPartner

youtu.be/IeX-GF-nLqo

Yearofthecow profile image
Yearofthecow in reply toDarryl

Thanks Darryl,

John

PSAed profile image
PSAed in reply toDarryl

Thanks Darryl/TA

As you suggested in the video ....certainly in my case...I will watch it more than once as there is a lot to take in.

backbonz profile image
backbonz

well this is certainly relevant for me since I’m starting SBRT Monday. I was happy that Dr. Nagar said i wouldn’t need Hormone therapy in my case. (low-int risk) .

Now this makes me think.

And then you read stuff like this…

pubmed.ncbi.nlm.nih.gov/354...

Yearofthecow profile image
Yearofthecow in reply tobackbonz

Problem with the ncbi link is that it is based on retrospective data so it is hard to determine the harm or benefit, as opposed to a double blind study I believe

PSAed profile image
PSAed

Thank you for post Yearofthecow. I do not understand what exactly constitutes 'whole pelvis radiation" eg in my case I received "Radiation to prostate, seminal vesicles, and Nodes ,total of 78 Gy in 39 fractions" Does this mean I received whole pelvis radiation?

I ask because in your link Amar Kishan makes a distinction between PORT and "whole pelvis RT" when drawing a conclusion from Data.

Yearofthecow profile image
Yearofthecow in reply toPSAed

I am not sure PSAed. I read PORT as only the prostate, while whole pelvis radiation would be the prostate plus the pelvic lymph nodes. My understanding is that the thinking among some is whole pelvic radiation is done as a prophylactic. I think because you had the lymph nodes done, that would imply whole pelvis RT. Perhaps others might add their thoughts here. Of course the easy answer is to ask your RO.

Take care,

John

Not what you're looking for?

You may also like...

Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies

https://healthunlocked.com/redirect?url=https%3A%2F%2Fwww.auajournals.org%2Fdoi%2F10.1097%2FJU.00000
maley2711 profile image

De-escellation of ADT with modern RT treatment

A bit of rethinking of the standard of care for intermediate and high-risk PCa cases - of long-term...
Don_1213 profile image

Short-term vs Long-Term ADT for High Risk Men

Here's a review of a recent presentation at ASCO 2023 by Artera.ai regarding the use of Artificial...
janebob99 profile image

Low testosterone is associated with extremely poor survival metrics, post-ADT.

These companion plots compare: (A) median survival times, (B) PSA doubling times, and (C) Time to...
janebob99 profile image

Low Testosterone reduces Survival by a huge amount.

This plot compares prostate cancer specific mortality probability versus time for two different...
janebob99 profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.